Among LysoPS receptors, LPS3 has been the best-characterized in the past few years, and accumulated clinical evidence suggests that LPS3 has a role in female-preponderant autoimmune diseases, such as Grave’s disease [57], Addison’s disease [58], and autoimmune thyroid disease [59]. This evidence concerns the gene GPR174 and autoimmune thyroid disease.